Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic controlled trial

被引:91
作者
Beghi, E
Gatti, G
Tonini, C
Ben-Menachem, E
Chadwick, DW
Nikanorova, M
Gromov, SA
Smith, PEM
Specchio, LM
Perucca, E
机构
[1] San Gerardo Hosp, Dept Neurol, Monza, Italy
[2] Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy
[3] Giuseppe Salvini Hosp, Dept Neurol, Garbagnate Milanese, Italy
[4] Sahlgrenska Hosp, Dept Neurol, Gothenburg, Sweden
[5] Walton Ctr Neurol & Neurosurg, Liverpool, Merseyside, England
[6] Inst Pediat & Pediat Surg, Moscow, Russia
[7] VM Bekhterev Psychoneurol Res Inst, St Petersburg, Russia
[8] Univ Wales Hosp, Dept Neurol, Cardiff CF4 4XW, S Glam, Wales
[9] Univ Bari, Dept Neurol, Bari, Italy
关键词
epilepsy; monotherapy; polytherapy; randomised controlled trial;
D O I
10.1016/j.eplepsyres.2003.09.007
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To evaluate the value of alternative monotherapy versus adjunctive therapy in partial epilepsy refractory to single antiepileptic drug (AED) therapy. Design and methods: In a multicentre, parallel-group, open-label study, patients with cryptogenic or symptomatic partial epilepsy not controlled after single or sequential AED monotherapies were randomised to monotherapy with an alternative AED or to adjunctive therapy with a second AED. The AED to be added/substituted and dose adjustments were determined by the physician's best judgement. Patients were followed up until withdrawal from the allocated treatment or for 12 months, whichever first. Outcome measures included proportion of patients continuing on the assigned treatment strategy, proportion of patients seizure-free after achieving the target maintenance dose, and adverse effects rates. Data were analysed by actuarial life tables, Kaplan-Meier survival analysis and Cox proportional hazard regression model. Results: Of a total of 157 patients (including 94 previously exposed to only one AED), 76 were randomised to alternative, monotherapy and 81 to adjunctive therapy. The two groups were balanced in clinical characteristics. The 12-month cumulative probability of remaining on the assigned treatment was 55% in patients randomised to alternative monotherapy and 65% in those randomised to adjunctive therapy (P = 0.74). The 12-month probability of remaining seizure-free was 14 and 16%, respectively (P = 0.74). Adverse effects were similar in the two groups. No significant differences in outcome within or between groups were identified based on etiology of epilepsy and previous AED exposure. Conclusions: Although these findings should be interpreted with caution due to the low statistical power resulting from the relatively small sample size, alternative monotherapy and adjunctive therapy were associated with similar outcomes. Further work is required to determine whether outcome could be improved through identification of specific AED combinations with synergistic activity. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 38 条
[1]  
[Anonymous], 1993, EPILEPSIA, V34, P592
[2]   Therapeutic strategies against epilepsy in Mediterranean countries: a report from an international collaborative survey [J].
Baldy-Moulinier, M ;
Covanis, A ;
D'Urso, S ;
Eskazan, E ;
Fattore, C ;
Gatti, G ;
Herranz, JL ;
Ibrahim, S ;
Khalifa, A ;
Mrabet, A ;
Neufeld, MY ;
Perucca, E .
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 1998, 7 (06) :513-520
[3]  
Barcs G, 2000, EPILEPSIA, V41, P1597
[4]  
BEGHI E, 1987, DEV MED CHILD NEUROL, V29, P363
[5]   THE MANAGEMENT OF EPILEPSY IN THE 1990S - ACQUISITIONS, UNCERTAINTIES AND PRIORITIES FOR FUTURE-RESEARCH [J].
BEGHI, E ;
PERUCCA, E .
DRUGS, 1995, 49 (05) :680-694
[6]   Carbamazepine toxicity with lamotrigine: Pharmacokinetic or pharmacodynamic interaction? [J].
Besag, FMC ;
Berry, DJ ;
Pool, F ;
Newbery, JE ;
Subel, B .
EPILEPSIA, 1998, 39 (02) :183-187
[7]   Lamotrigine substitution study: Evidence for synergism with sodium valproate? [J].
Brodie, MJ ;
Yuen, AWC .
EPILEPSY RESEARCH, 1997, 26 (03) :423-432
[8]   Polytherapy in epilepsy: the experimental evidence [J].
Czuczwar, SJ ;
Borowicz, KK .
EPILEPSY RESEARCH, 2002, 52 (01) :15-23
[9]   Monotherapy versus polytherapy for epilepsy: A multicenter double-blind randomized study [J].
Deckers, CLP ;
Hekster, YA ;
Keyser, A ;
van Lier, HJJ ;
Meinardi, H ;
Renier, WO .
EPILEPSIA, 2001, 42 (11) :1387-1394
[10]   Selection of antiepileptic drug polytherapy based on mechanisms of action: The evidence reviewed [J].
Deckers, CLP ;
Czuczwar, SJ ;
Hekster, YA ;
Keyser, A ;
Kubova, H ;
Meinardi, H ;
Patsalos, PN ;
Renier, WO ;
Van Rijn, CM .
EPILEPSIA, 2000, 41 (11) :1364-1374